Ashton Thomas Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
10,137
+1,866
+23% +$218K 0.19% 114
2026
Q1
$995K Buy
8,271
+1,242
+18% +$143K 0.12% 166
2025
Q4
$740K Buy
7,029
+45
+0.6% +$4.22K 0.14% 138
2025
Q3
$586K Buy
6,984
+759
+12% +$62.5K 0.08% 209
2025
Q2
$493K Sell
6,225
-382
-6% -$30.4K 0.12% 171
2025
Q1
$589K Sell
6,607
-663
-9% -$61.9K 0.16% 141
2024
Q4
$726K Buy
7,270
+4,199
+137% +$433K 0.2% 121
2024
Q3
$349K Buy
3,071
+217
+8% +$25.8K 0.07% 213
2024
Q2
$360K Buy
+2,854
New +$368K 0.09% 176

Other funds holding MRK

Ashton Thomas Securities's MRK Position: Q2 2026 in Review

Ashton Thomas Securities increased its Merck (MRK) stake by 23% in Q2 2026, buying an estimated $218K and bringing the position to 10,137 shares worth $1.29M. The position accounts for 0.19% of the portfolio, ranked #114.

Ashton Thomas Securities first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ashton Thomas Securities held 10,137 shares of Merck worth $1.29M as of Q2 2026.
  • Ashton Thomas Securities bought 1,866 Merck shares in Q2 2026, an estimated $218K.
  • Merck made up 0.19% of Ashton Thomas Securities's portfolio in Q2 2026, its #114 holding.
  • Ashton Thomas Securities first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.